Michael Corbo currently serves as SVP and Chief Development Officer for Inflammation & Immunology at Pfizer, leading pivotal global development initiatives from Phase 2b through Phase 4 and managing end-to-end development for Pfizer's portfolio in China. Previously, Michael held the role of Senior Vice President and Chief Development Officer, overseeing the global development of Pfizer's Biosimilars Portfolio. Additionally, Michael served as Senior Vice President and Category Development Lead for Immunology & Inflammation, responsible for full program leadership up to regulatory approval. Prior experience includes a role as Vice President and Development Lead at Bristol-Myers Squibb, where Michael contributed to the development of ORENCIA (abatacept). Michael holds a degree from Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices